PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
1395397-6	1992	With thrombin concentrations above 100 U/ml, a significant reduction in WBCT is recorded, but although there is a trend of increasing CPA with increasing thrombin concentration from 200-1000 U/ml, a plateau in WBCT is seen, and the difference is not significant.	cpa	134-137	coagulation factor II, thrombin	Homo sapiens	154-162	
17493358-1	2007	The study was purposed to develop a novel cryopreserved agent (CPA) for platelets, to investigate the morphology of cryopreserved platelets in different CPA and the CD62P expression on membrane of platelets after stimulating by thrombin, as well as to compare the effect of adding UDP-Gal on preserved efficiency of preservation solutions.	cpa	63-66	coagulation factor II, thrombin	Homo sapiens	228-236	
20656333-4	2010	Compared with controls, patients had a higher CPA (24.0+/-9.0 vs 10.6+/-4.4 nM, p<0.001), which was associated with a lower inhibition of the thrombin generation in the presence of TM (20.1+/-9.5% vs 28.4+/-11.8%, p<0.001), compatible with a low sensitivity to TM.	cpa	46-49	coagulation factor II, thrombin	Homo sapiens	145-153